Research posts displayed by category

The President's Message-June

The President’s Message

Check out the June issue of The President’s Message.

It includes:

  • Dr. Perman’s column on last month’s State of the University Address
  • A recap of commencement, UMB’s Neighborhood Spring Festival, Glendening and Ehrlich’s political discussion, and the CURE Scholars’ end-of-year celebration
  • A look ahead to Dr. Perman’s June 19 Q&A
  • Stories on philanthropic gifts to the schools of medicine and nursing
  • Two more employees benefit from the Live Near Your Work Program
  • UMB police start active shooter response training
  • A roundup of student, faculty, and staff achievements
Chris ZangABAE, Bulletin Board, Clinical Care, Collaboration, Community Service, Contests, Education, For B'more, People, Research, Technology, UMB News, University Life, USGAJune 11, 20180 comments
Read More
Alexander MacKerell at the CADD Symposium

CADD Symposium Shows Collaboration is Key in Drug Discovery

The Computer-Aided Drug Design (CADD) Center — an organized research center at the University of Maryland, Baltimore (UMB) that is housed within and led by faculty at the University of Maryland School of Pharmacy — welcomed researchers from across academia, government, and industry to its biennial CADD Symposium on May 23. Designed to facilitate collaborations between the CADD Center and researchers across the University System of Maryland and beyond, the symposium presented recent developments in the fields of drug design and development and offered opportunities for researchers to network and discuss potential collaborations.

“As researchers, we know that collaboration is key not only to the success of our individual projects, but also to the advancement of science as a whole,” says Peter Swaan, PhD, professor in the Department of Pharmaceutical Sciences (PSC) and associate dean for research and graduate education at the School of Pharmacy, who offered opening remarks to attendees. “For nearly 20 years, the CADD Center has been phenomenally successful in its efforts to foster collaborative research between biologists, biophysicists, structural biologists, and computational scientists. In addition to highlighting the latest advances in computational chemistry, this symposium explores how the research being conducted in this field can be applied to solve important biological and clinical problems in other areas.”

Bringing Experimentalists and Computational Chemists Together

The symposium was organized by Alexander MacKerell, PhD, the Grollman-Glick Professor of Pharmaceutical Sciences and director of the CADD Center at the School of Pharmacy, who kicked off the event alongside David Weber, PhD, professor of biochemistry and molecular biology and director of the Center for Biomolecular Therapeutics at the University of Maryland School of Medicine. The two researchers presented an overview of the drug discovery initiatives being pursued by scientists across UMB.

“By combining experimental methods with computational methods, we can help expedite the drug design process,” MacKerell said. “On their own, experimental and computational methods are very useful. However, when you combine the information, it works in a synergistic fashion to move the science ahead. Each problem is unique, and selecting the appropriate methodology to apply can be challenging. That is why researchers at the CADD Center regularly interact with experimentalists to take the idea from the basic science stage and identify compounds that can be molded into new drug candidates and brought to the market.”

Pioneering the Development of Biologic Drugs

Sponsored by the School of Pharmacy, SilcsBio LLC, and Early Charm Ventures, this year’s symposium focused on biologics. Unlike most medications that are developed through chemical syntheses, biologics — which include vaccines, certain medications for cancer and autoimmune diseases, as well as emerging drugs for cell and gene therapies — are made with living cells and represent the cutting edge of biomedical research, often succeeding where traditional drug treatments have failed.

The symposium featured presentations from a number of faculty members at the School of Pharmacy, including Bruce Yu, PhD, professor in PSC and director of the school’s Bio- and Nano-technology Center, who presented his work to develop a water proton nuclear magnetic resonance (NMR) technology that uses a benchtop device to perform non-invasive chemical analyses to help ensure the quality of biologics throughout the manufacturing process. Explaining that there are a number of errors that can occur during the pharmaceutical manufacturing process, Yu noted that his benchtop device would allow manufacturers and health care practitioners, such as pharmacists and doctors, to detect these rare but serious product defects before the drug is dispensed to a patient.

“Think about weather forecasting,” Yu said. “Meteorologists use large supercomputers to help formulate their predictions for the week’s upcoming forecast. However, the average individual also has access to an app on his or her smartphone that can display that same forecast whenever it is opened. That is how we think about our work — this benchtop device will be the app equivalent of the large NMR spectrometers with which many of us are already familiar.”

Showcasing Regional Research

Additional presenters from the School of Pharmacy included Jana Shen, PhD, associate professor of PSC and co-director of the CADD Center, who presented her work on incorporating pH in structure-based drug design; Stephen Hoag, PhD, professor of PSC and director of the Good Manufacturing Practice (GMP) Facility at the school, who spoke about the formulation of therapeutic antibodies for colonic delivery; and Lisa Jones, PhD, assistant professor in PSC, who highlighted her efforts to examine protein structure in vivo (within living organisms).

Embracing the CADD Center’s pharmapreneurial spirit, the symposium also included a presentation by the Office of Technology Transfer at UMB, which spotlighted the University’s commitment to helping faculty bring their new technologies into commercial development.

Other presentations were delivered by Jeffrey J. Gray, PhD, professor in the Department of Chemical and Biomolecular Engineering at Johns Hopkins University; Sandeep Somani, PhD, senior scientist at Janssen Pharmaceuticals; Joseph Curtis, PhD, research chemist at the National Institute of Science and Technology (NIST); Luke Arbogast, PhD, research chemist at NIST; Eric Sundberg, PhD, professor of medicine and co-director for the Basic Science Division with the Institute of Human Virology at the University of Maryland School of Medicine; Alex Drohot, PhD, associate professor of biochemistry and molecular biology at the School of Medicine; and Suresh Singh, PhD, vice president of HotSpot Therapeutics.

“I attended the CADD Symposium because I was interested in learning more about computer-aided drug design,” said Ben Nkapbela, an undergraduate student at York College of Pennsylvania. “I truly value all of the connections that I have made with other researchers during my time at the symposium as well as all of the information that I have gained from listening to the presentations.”

The symposium concluded with a poster session that offered attendees the opportunity to learn more about the cutting-edge research being conducted across the regions.

To watch a video about the symposium, go to YouTube.

Malissa CarrollCollaboration, Research, UMB NewsJune 8, 20180 comments
Read More
Dr. Noel Wilkin

Pumpian Lecture Explores Meaning in Pharmacy Profession

Chasing innovation — being an entrepreneur — is not an easy task, especially when creative or financial resources are limited. So why would an individual willingly choose to pursue such a difficult endeavor?

This was the question Noel E. Wilkin, RPh, BSP ’89, PhD ’97, provost and executive vice chancellor for academic affairs and professor of pharmacy administration at the University of Mississippi, sought to answer as he delivered the annual Paul A. Pumpian Memorial Lecture at the University of Maryland School of Pharmacy on April 11.

More than Money

Titled “Innovation and Meaning: The Building Blocks of Entrepreneurship and Professional Satisfaction,” Wilkin’s lecture focused on a grant he received from the National Community Pharmacists Association (NCPA) that aimed to encourage pharmacists to implement more innovative approaches in their practices by demonstrating how profitable such innovations could be for the pharmacy.

However, Wilkin was quick to explain that the results of his research did not quite match his funders’ original hypothesis.

“NCPA was convinced that pharmacies would innovate if we could demonstrate how profitable it was for pharmacists,” said Wilkin, who also serves as a research professor for the Research Institute of Pharmaceutical Sciences at the University of Mississippi. “But our team quickly recognized that there was no profitability source. We had 300 pharmacists coming to a sponsored breakfast to learn about how to innovate and how to be profitable, and we had nothing to tell them. We were panicking.”

Do What Makes You Happy

Wilkin and his team conducted interviews at 14 pharmacies across the country to learn about the factors that motivated those pharmacists to innovate in their practices. Although none of the pharmacists reported increased profits as a motivator or result of incorporating their innovations into their practice, they explained that their innovations left them feeling a high level of personal and professional satisfaction. One pharmacist interviewed by Wilkin even described his motivation to rearrange his practice by saying, “My lawn service calls me before I need my lawn serviced. Why can’t my pharmacist call and talk to me about my medications before I need my prescriptions refilled?”

Although Wilkin appreciated the honesty with which the pharmacists responded to his questions, he struggled to frame the results in a way that would encourage other pharmacists to pursue innovation in their own practices. It was an episode of The Daily Show with Jon Stewart that led Wilkin to his greatest epiphany surrounding the reasons that pharmacists might still choose to pursue innovation even in the face of constrained resources.

“I’m lying awake thinking about this problem, and Jon Stewart began interviewing a man named Tal Ben-Shahar, a faculty member at Harvard who had just written a book titled Happier,” Wilkin recalled. “And, as I laid there listening to him talk about people who are pursuing meaning in their lives and how it made them happier, it clicked. Pharmacists were not innovating because they were motivated by money. They were not innovating because the pharmacy profession told them it was what they ought to do. Instead, they were doing it because it made them happy.”

Find Meaning in Your Work

Wilkin then further examined personal motivators, such as identity and purpose, as potential drivers behind pharmacists’ desire to innovate in their practices.

“We know that identity drives actions,” he said. “Our purpose is manifested in our roles; it gives us a sense of direction. Accepting the role of being health care professionals affects our actions and outlines our purpose. It is our reason for being, and success in this role is then knowing our purpose, growing to reach our potential, and sowing those seeds to help others.”

He also explored the concept of “meaning,” noting that if pharmacists have accepted their role as health care professionals, pharmacies can further energize their performance by ensuring that the activities in which they are engaged relate to their purpose and have significant value or an impact on others — or, in other words, are meaningful.

“Meaning is self-generated,” Wilkin said. “It’s based on your experiences and linked to the circumstances that you accept in your life and that define your purpose. It’s also linked to, I believe, happiness. It’s the pursuit of meaning on an everyday basis and on a long-term basis that helps you to appreciate and understand happiness.”

Strive for Lasting Happiness

Wilkin argued that happiness is not a dichotomy in which a person is or is not happy at a given time, as many people think. Instead, he posited that all individuals, including pharmacists, can achieve sustained happiness by engaging in activities that offer both an immediate, present benefit as well as goals that they can strive to achieve in the future (or future benefit). “If you get in touch with what you believe is your meaning and it brings you present benefit and future benefit, then it’s going to result in greater happiness and, ultimately, it will help you find direction as you engage in activities that are connected to your roles in society,” he said.

To conclude his lecture, Wilkin revisited the pharmacists he interviewed during his NCPA-funded study.

“Pharmacists have incredible opportunities to find purpose and meaning in their work,” he said. “For the pharmacists that we interviewed, the purpose and meaning that they found wasn’t a function of profitability; it wasn’t a function of them making more money. Instead, it was a function of them finding incredible meaning in their life — taking daily pleasure in their work and the benefit they found in interacting with patients on a day-to-day basis, while also keeping sight of their overall goal and drive to improve the health of their patients.”

Malissa CarrollPeople, Research, UMB NewsJune 7, 20180 comments
Read More

SOP’s Hollenbeck Honored with Distinguished Alumnus Award

The Purdue University College of Pharmacy has named R. Gary Hollenbeck, PhD, affiliate professor in the Department of Pharmaceutical Sciences (PSC) and research fellow in the Good Manufacturing Practice (GMP) facility at the University of Maryland School of Pharmacy, one of its 2018 Distinguished Pharmacy Alumni. Established in 1984, the award celebrates the outstanding achievements in professional and scientific endeavors of the college’s most prominent alumni.

Hollenbeck is one of four alumni from the college to be recognized with the award this year.

“Our department was thrilled to hear about Dr. Hollenbeck’s recognition as one of Purdue University College of Pharmacy’s distinguished pharmacy alumni,” says Paul Shapiro, PhD, professor and chair of PSC. “During his time at the School of Pharmacy, Dr. Hollenbeck has had an indelible impact on the advancement of pharmacy education and pharmaceutical research, spearheading the launch of both the School’s Doctor of Pharmacy (PharmD) program and GMP facility. His alma mater certainly chose well in selecting him to receive this prestigious honor, and we congratulate him on this award.”

Advancing Pharmacy Education

Hollenbeck received his Bachelor of Science degree in pharmacy from Albany College of Pharmacy in 1972 and completed his doctorate in industrial and physical pharmacy at Purdue University in 1977. He joined the University of Maryland School of Pharmacy as an assistant professor in 1977, rising through the ranks to become a professor of pharmaceutical sciences and associate dean for academic programs. During his service as associate dean for academic programs from 1991 to 1996, Hollenbeck played a key role in the transition from the school’s Bachelor of Science program to its now nationally recognized PharmD program.

“The School of Pharmacy was the first pharmacy school on the East Coast to transition to the entry-level PharmD program,” Hollenbeck says. “I worked alongside our faculty to establish an unprecedented curriculum that was focused on instructional design, student abilities, and outcomes. In fact, many of the elements that we incorporated into our initial program still exist in the curriculum today.”

Pioneering New Research Collaborations

In addition to his numerous achievements as an educator — which include receiving the school’s Outstanding Teacher Award in 1980 and 1984, being named the school’s Teacher of the Year in 1991, and being selected as the University of Maryland, Baltimore (UMB) Founders Week Teacher of the Year in 2002 — Hollenbeck was instrumental in securing  a multimillion-dollar collaborative agreement with the Food and Drug Administration (FDA), which aimed to establish a scientific basis for the review of new and amended drug applications. This collaborative agreement also provided the initial funding to establish a GMP facility at the School of Pharmacy.

“What began as a conceptual document ultimately led to one of the most successful collaborations between the FDA, industry, and academia ever,” says Hollenbeck, who, along with his associates, received a Special Recognition Award from the Center for Drug Evaluation and Research at the FDA to recognize of their work on the project in 1996.

In 1997, Hollenbeck became a principal figure in the formation and development of UPM Pharmaceuticals, Inc., an independent contract development and manufacturing organization serving the pharmaceutical and biotechnology industries. He later joined the company as its chief scientific officer, before returning to the School of Pharmacy in 2016, where he participates in early-stage pharmaceutical research and development and directs clinical supplies production in the GMP facility.

Recognizing Where It All Began

Though most of his career accomplishments have been associated with the School of Pharmacy, Hollenbeck emphasizes that it was the knowledge and training that he received from the Purdue University College of Pharmacy that helped put him on the path to success.

“It would in no way be an overstatement to say that the Purdue educational experience transformed my life,” Hollenbeck says. “Small-town boy on a Big Ten campus — I discovered myself. I was fortunate to find the perfect program for me and to matriculate with such a wonderful group of faculty and graduate students. The degree I earned at Purdue opened the door to an incredibly rewarding professional career.”

Hollenbeck received his award during a ceremony held at the Purdue University College of Pharmacy on April 6.

— Malissa Carroll

 

Malissa CarrollPeople, Research, UMB NewsMay 22, 20180 comments
Read More

Discover and Share Data with New UMB Data Catalog

The Health Sciences and Human Services Library (HS/HSL) is proud to introduce the UMB Data Catalog, a searchable and browsable collection of records describing datasets generated by UMB researchers.

The UMB Data Catalog promotes research collaboration and data sharing by facilitating the discovery of data sets that may be otherwise hard to find or unavailable from data repositories. Rather than functioning as a repository to store data, the Data Catalog provides information about data sets, including a description of the data set, keywords,  file format and size, access rights, and links to associated articles. With the UMB Data Catalog, researchers can describe their data and make it discoverable, but they are not required to share their data. Instead, the catalog allows users to request data access through an author, an administrator, or a repository. By allowing researchers to identify common research interests and by supporting the sharing and reuse of research data, the UMB Data Catalog has the capacity to promote interdisciplinary collaboration.

The HS/HSL is a member of the Data Catalog Collaboration Project (DCCP) along with New York University (NYU); the University of Pittsburgh; the University of Virginia; the University of North Carolina, Chapel Hill; and Duke University. Members run their own installations of the data catalog, developed by NYU, but work together to share and improve system design, content curation, and outreach efforts.

The HS/HSL thanks the researchers who have contributed to the UMB Data Catalog during its initial development phase.

  • Sergei P. Atamas, MD, PhD, School of Medicine
  • Peter Doshi, PhD, School of Pharmacy
  • Corey Shdaimah, LLM, PhD, School of Social Work
  • Jay Unick, MSW, PhD, School of Social Work

Help us build the UMB Data Catalog! If you are interested in submitting a data set, have a suggestion for additional data sets to add, or need more information about the project, please contact us.

Everly BrownCollaboration, Education, Research, TechnologyMay 22, 20180 comments
Read More

UMMC Schwartz Rounds: ‘When Tragedy Strikes and Compassion Wanes’

The University of Maryland Medical Center will host a Schwartz Rounds forum May 29 that is open to all employees. The topic: “Amidst Embers: When Tragedy Strikes and Compassion Wanes.”

Join our monthly multidisciplinary forum and engage with caregivers in a conversation about the emotional and social issues associated with caring for patients. Panelists will present case studies and facilitate an interactive discussion in which participants can share their experiences.

Here are the details:

  • When: Tuesday, May 29
  • Time: Noon to 1 p.m.
  • Where: UMMC Auditorium, 22 S. Greene St., Baltimore, MD 21201
  • Registration: Go to this link.
  • Note: Lunch will be provided.
  • Continuing education: Physicians, nurses, respiratory therapists, and social workers who attend will be eligible to earn one AMA PRA Category 1 credit, one Nursing Continuing Education Hour, or one SW Category 1 CEU.
Briana MathisClinical Care, Education, Research, UMB News, University LifeMay 22, 20180 comments
Read More

Seeking Participants to Screen for Elevated Blood Sugar Levels

Researchers at the University of Maryland School of Medicine want to learn about the use of a commercially available dietary supplement for men and women who are prediabetic.

This study may be a good fit if you are:

  • Male or female, 18 years of age or older
  • Prediabetic determined by elevated blood glucose or HbA1c (possible risk factors for prediabetes include being overweight, inactive, and family history)

Participants who take part in the screening will receive $25 for their time (additional payment if eligible and enrolled in the research study).

If you decide to take part in the screening for this research, you would:

  • Attend one visit to have a fasting blood sample drawn to determine your glucose level
  • Have the opportunity to enroll in the study if eligible
  • Once enrolled, attend two 45-minute appointments over 12 weeks
  • Have bloodwork completed at both appointments
  • Participate in a short phone call midway through the study
  • Take four dietary supplement capsules per day for 12 weeks

Contact information

Mary Bahr-Robertson
Email: mbahr@som.umaryland.edu
Phone: 410-706-6155

The principal investigator for this study is Chris D’Adamo, PhD

Deborah TaberResearch, University LifeMay 16, 20180 comments
Read More

HS/HSL Information on Access to Resources for UMB Graduates

As the academic year comes to a close, the Health Sciences and Human Services Library would like graduating students to know what resources they can use after graduation.

Journals and databases: Alumni retain access to HS/HSL’s electronic resources for two months after graduation. After that, you will need to visit the Library to use the on-site computers.

RefWorks: If you have saved references in RefWorks, consider migrating them to a freely available tool so you do not lose them when your access expires two months after graduation. Two free options, Mendeley and Zotero, are described on our Other Citation Managers page.

Free databases: Once your electronic access expires, you will still have access to public databases for literature, drug information, and more. A few examples are highlighted here in the May 2018 Connective Issues. Additionally, be sure to investigate what resources you have through your new workplace and any professional organizations of which you are a member.

Everly BrownEducation, Research, University Life, USGAMay 14, 20180 comments
Read More

The President’s Message

Check out the May issue of The President’s Message.

It includes the following:

  • Dr. Perman’s column on a new home for our Community Engagement Center
  • A recap of IPE Day
  • A look ahead to commencement
  • Dr. Robert Redfield’s appointment as CDC director
  • A Women’s History Month celebration of Dr. Angela Brodie
  • Shock Trauma’s Stop the Bleed program
  • A roundup of student, faculty, and staff achievements
Chris ZangABAE, Bulletin Board, Clinical Care, Collaboration, Community Service, Education, For B'more, People, Research, Technology, UMB News, University Administration, University Life, USGAMay 10, 20180 comments
Read More

Check Out the Latest ‘Connective Issues’ Newsletter

The May 2018 issue of the Connective Issues newsletter from the Health Sciences and Human Services Library (HS/HSL) is now available.

Included in this issue:

  • The GDPR – Why Should We Care?
  • Virtual Reality Headset Available at HS/HSL Innovation Space
  • Fruit Ninja VR Study Break Contest – Game On
  • Discover and Share Data with the New UMB Data Catalog
  • Advice for Grads
  • Movable Monitors Roam the HS/HSL
  • HS/HSL Historical Collection Open House Event
Everly BrownContests, Education, Research, TechnologyMay 10, 20180 comments
Read More

Dry Eye Study: Complete It and Receive $200

The University of Maryland Department of Ophthalmology and Visual Sciences is participating in a dry eye study to determine how your environment affects your eyes.

The study involves two visits to our Redwood Street practice and two visits to your home. You will receive $200 compensation for your time. To register or for more information, contact Joby Tsai at joby.tsai@som.umaryland.edu.

Merideth MarrBulletin Board, Clinical Care, People, Research, University LifeMay 7, 20180 comments
Read More

Ehrlich, Glendening Discuss Federal-State Relations, Political Divisions

Robert L. Ehrlich Jr., JD, and Parris N. Glendening, PhD, MA, come from different sides of the political aisle and hold opposing views on many issues. But both share the title of former Maryland governor, and they agree on what’s causing the breakdown in cooperation between federal and state governments: hyper-partisanship and a Congress that is broken.

“There has been a dramatic change in what is permissible and encouraged with partisan bitterness,” said Glendening, who joined Ehrlich on May 1 at the University of Maryland, Baltimore in the sixth installment of the UMB President’s Panel on Politics and Policy.

Glendening added, “You combine that with no one consulting in the intergovernmental area, and I’ll sum it up with a rather dark statement, which comes from a recent book about journalism: ‘The absence of an intergovernmental system, which would facilitate consultation, coordination, and compromise, combined with the extraordinary negatives of current political debate, is bad public policy, bad for our politics, and bad for our country.’”

Ehrlich agreed that the system is dysfunctional because of all the hostility between the political parties, but he added, “This is not new. When people fight over power, this is a byproduct. It’s just the vitriol has crossed a line lately.”

The two ex-governors – Republican Ehrlich succeeded Democrat Glendening in 2003 after the latter had served two terms – also talked about marijuana legalization, gerrymandering district boundaries, and federal-state cooperation in Maryland at the panel, which was moderated by veteran broadcast journalist Bruce DePuyt, senior reporter for the Maryland Matters website. The panel series was launched by UMB President Jay A. Perman, MD, in January 2017 to examine issues important to the University community that are likely to be affected by the Trump administration and Congress.

Perman introduced Ehrlich and Glendening to the crowd of nearly 200 UMB staff, faculty, and students at the SMC Campus Center, saying, “There are no two better guests to discuss the role of federal actors in state policy than the two we have with us today.” With that, the ex-governors talked about their relationship – “We can differ on policy and still be civil and still be friends,” Glendening said — before enlightening the crowd with their political and policy insights.

Glendening, who is now the president of Smart Growth America’s Leadership Institute and the Governors’ Institute on Community Design, opened by saying the name of the event, “The Intersection of Federal Policy and State Priorities,” should be changed to “The Decline of an Intergovernmental System and the Emergence of Extreme Personal Politics – A Bad Mix.” He traced the roots of federal and state governments working together to the 1930s, adding that by the 1970s most federal agencies and states had created offices to foster cooperation.

“Think about the last year, think about the changes in immigration laws and the new tax law, they were totally devoid of any intergovernmental discussions or any real bipartisan talks,” he said. “They’re looking at a new infrastructure program, but there is no input from state and local government. And there is chaos in the enforcement of marijuana laws” between states that allow medicinal or recreational use and federal law that forbids it.

Glendening favors allowing marijuana use for either purpose, whereas Ehrlich is in favor of medicinal use only.

“None of us takes the issue of yet another way to get high lightly. If we do that, we do it to our own detriment,” said Ehrlich, who is now senior counsel in the Government Advocacy and Public Policy practice group at King & Spalding LLP in Washington, D.C. “With regard to end-of-life situations, with regard to terminal pain situations, I’m for all of the above.”

Glendening compared the reform in marijuana laws, with 29 states having various degrees of legalization, to recent changes in gay rights, gay marriage, and immigration (states and cities creating so-called sanctuary cities), as being indicative of local governments serving as “laboratories of democracy.”

“I see it as good policy change coming from the states from the bottom up,” he said. “I’ll make this guarantee: The federal government will move to the same broad interpretations on marijuana – against illegal, organized distribution but permitting individual use under a regulatory system.”

‘Safe Seats’ Dangerous to Democracy

Switching back to politics, the practice of gerrymandering – manipulating the boundaries of voting districts to favor one party – came in for particular scrutiny, because the redrawing of congressional lines has created “safe seat” districts where incumbents face no real challenge from the opposing party.

“This is why there’s all this interest in primaries as opposed to general elections,” said Ehrlich, who served four terms in Congress before becoming Maryland’s first Republican governor in 36 years. “Because when you have a safe seat, your fight is generally going to be in a primary from further right or further left, not from the other party. And when you have lots of safe seats, which you have in the House of Representatives today, you generally have a lack of incentive to sit down and try to negotiate.”

Glendening, who served three terms as Prince George’s County executive and was a university professor at College Park for 27 years, agreed that redistricting has exacerbated partisanship, noting that Maryland’s delegation in the House has gone from a 4-4 split in the 1990s to 7-1 in favor of the Democrats.

“With computers and everything else, you are able to draw a line — literally go down the street, turn on this corner, turn here, and you look at voting patterns and you can go out in two hours and draw a district that is to your liking,” he said. “So now you are in a district that is extreme. There’s no center to that district. And you can do and say anything you want, as long as you keep that base happy. And it’s the Democrats and the Republicans doing this.”

‘Team Maryland’ Works Together

Democrat and Republican politicians in Maryland, however, have a great history of state-federal cooperation, both men said, suggesting that this should be a model for cooperation in Congress. Ehrlich pointed to two Maryland political legends – Barbara Mikulski in the Senate and Helen Delich Bentley in the House – as being particular supportive during his term.

“They both made it very clear that this is Team Maryland, and we need to work together,” Ehrlich said. “So egos, philosophical differences, and party were put aside. This is your uniform, and it’s yellow and black.”

Glendening said Maryland’s tradition of bipartisanship in this regard is because it’s a smaller state where many federal employees reside and relies on many aspects of federal expenditures.

“When I was governor, there were four Democrats and four Republicans in the House delegation, and you wouldn’t have known that if you were sitting in those meetings,” he said. “And that preceded weeks of meetings with staff to start to work out the details. It was a good system, and it still functions. The problem is, Congress is not functioning as well.”

When asked by an audience member if there was any hope that the acrimony between the major political parties would ease, Ehrlich answered succinctly: “No.”

But he expounded, saying, “In D.C. today, both parties do not respect rules. It’s dysfunctional. This is a structural problem, and it’s a serious problem.”

But Glendening, saying he was an eternal optimist, offered hope.

“Our country has faced challenges like this in the past. And just as we have prevailed and we have changed, I believe we can do so now,” he said. “I’m reminded somewhat of the biblical observation: This too shall pass. And that gives me the strength to keep going.”

— Lou Cortina

Read more about the UMB President’s Panel on Politics and Policy.

Lou CortinaResearch, UMB News, University Administration, University LifeMay 2, 20180 comments
Read More

HS/HSL’s Historical Collections Holding Open House on May 9

The Health Sciences and Human Services Library’s (HS/HSL) Historical Collections is opening the doors to its unique and valuable collections on Wednesday, May 9, from 10 a.m. to noon.

Join the library to experience some of the treasures from its historical collections. Light refreshments will be served in the hallway outside of the Woodward Historical Suite.

Attendees will be able to:

  • Peruse select volumes from the Dr. John Crawford Collection, which founded the library in 1813.
  • Read the Walter Reed/James Carroll correspondence from the fourth U.S. Army Yellow Fever Commission, which discovered the cause of the disease in 1900.
  • Flip through the pages of the collection’s oldest volume, De Medicina, published in 1497.
  • View two exhibits highlighting the University’s involvement and experience in World War I and the 1918 influenza epidemic.
  • Learn more about the exceptional history of the University of Maryland, Baltimore.
  • Meet Tara Wink, the HS/HSL’s new historical librarian and archivist.

All are welcome and encouraged to attend. For additional information, contact Wink via email twink@hshsl.umaryland.edu or by calling 410-706-5048.

Tara WinkEducation, People, Research, University LifeApril 30, 20180 comments
Read More

Enhance UMB’s Social Media Efforts With This Online Survey

The University’s Office of Communications and Public Affairs wants your input on UMB’s social media. Complete our survey and let us know how we can better improve our engagement, content, and social presence.

Your input will help the office define our communications with the UMB community. The survey should take no more than 10 minutes, and we assure that all answers provided with be kept in the strictest confidentiality. Please complete the survey by Friday, May 25.

Click here to take the survey.

Kristi McGuireBulletin Board, Collaboration, People, Research, University LifeApril 20, 20180 comments
Read More

Integrative Medicine Congress to be Held in Baltimore in May

The International Congress on Integrative Medicine & Health will take place at the Baltimore Marriott Waterfront on May 8-11, 2018. The congress is convened by the Academic Consortium for Integrative Medicine & Health, a group of 71 esteemed academic health centers and affiliated institutions. The consortium is committed to making this congress the premier international forum for integrative medicine research.

The congress will bring together the best and the brightest working globally in the field of integrative medicine and health. Connect, share, learn, and collaborate in this dynamic community, where the leading work is being done via research, clinical care, policy, and education.

Former Sen. Barbara Mikulski of Maryland will be the special guest speaker. Other speakers include UMB President Jay A. Perman, MD; Alessio Fasano, MD; Steven Woolf, MD, MPH; Peter Wayne, PhD; Tracy Gaudet, MD; and Helene Langevin, MD.

Additionally, faculty and staff from the University of Maryland School of Medicine will have posters and presentations on a variety of topics and several faculty members will be leading after-hours events.

Integrative medicine is the practice of medicine that reaffirms the importance of the relationship between practitioner and patient, focuses on the whole person, and is informed by evidence. Integrative medicine includes many disciplines, types of practitioners, and therapeutic approaches; the evidence base is complex and growing quickly. The International Congress on Integrative Medicine & Health focuses on the evidence base in the practice of integrative medicine. We expect more than 1,200 researchers, clinicians, and trainees from around the world to attend. The congress organizers invite individuals from all disciplines and professions engaged in integrative medicine and health to attend.

The congress will showcase original scientific research through keynote and plenary sessions, oral and poster presentations, and innovative sessions. Research areas to be presented and discussed include basic science, clinical trials, lifestyle and prevention, methodology, health services, cost effectiveness, and education.

For more information and to register, visit this link.

Rebekah OwensBulletin Board, Clinical Care, Collaboration, Education, For B'more, People, Research, UMB NewsApril 17, 20180 comments
Read More